Tatva Chintan Pharma Chem Limited (TATVA.NS) share price
Tatva Chintan Pharma Chem Limited (NSE:TATVA.NS) last traded at INR 1,624.4, down 2.47% on the day (quote 2026-11-08 10:00 UTC), with a market cap of INR 3799.8 Cr and a 52-week range of INR 1,044.1 to INR 2,113.6.
| Exchange | NSE |
|---|---|
| Currency | INR |
| Last price | INR 1,624.4 |
| 1-day move | -2.47% |
| 52-week range | INR 1,044.1 - INR 2,113.6 |
| Market cap | INR 3799.8 Cr |
| From 52-week high | -23.10% |
| Volume vs average | 0.1x |
| Falling Shares risk score | 16/100 (MODERATE) |
| Country | India |
| ISIN | INE0GK401011 |
Frequently asked questions
Why is Tatva Chintan Pharma Chem Limited falling today?
Tatva Chintan Pharma Chem Limited (NSE:TATVA.NS) is down 2.47% at its latest quote and trades 23.1% below its 52-week high. A price fall alone does not identify a cause: Falling Shares Intelligence links a move to a filing, order or news item only when a source supports it.
What is the Tatva Chintan Pharma Chem Limited share price today?
Tatva Chintan Pharma Chem Limited (NSE:TATVA.NS) last traded at INR 1,624.4, a -2.47% move on the day as of 2026-11-08 10:00 UTC. Market data comes from public feeds and may be delayed; it is not investment advice.
What is the 52-week range of Tatva Chintan Pharma Chem Limited?
Tatva Chintan Pharma Chem Limited's 52-week low is INR 1,044.1 and its 52-week high is INR 2,113.6; the shares trade 23.1% below the high.
What is the market cap of Tatva Chintan Pharma Chem Limited?
Tatva Chintan Pharma Chem Limited has a market capitalisation of about INR 3799.8 Cr at the latest price.
What are the risks of investing in Tatva Chintan Pharma Chem Limited?
Falling Shares Intelligence rates Tatva Chintan Pharma Chem Limited 16/100 (MODERATE) on price stress, volume and disclosure signals. Risk scores are analytical indicators, not allegations or investment advice. Review exchange filings and the company's own disclosures before any decision.
Data is compiled from public exchange feeds and may be delayed. Not investment advice.
Wung Thomas, Editor-in-Chief: wungthomas@fallingshares.com. General enquiries and corrections: info@fallingshares.com